The CYP2C9 gene encodes a member of the cytochrome P450 superfamily. It metabolizes many pharmaceuticals, including phenytoin, tolbutamide, ibuprofen and S-warfarin (phenprocoumon). With certain mutations, patients under oral anticoagulation may show an increased risk of bleeding.
| Clinic | Method | Massive parallel sequencing |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |
| Research | Method | Genomic sequencing of the entire coding region |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |
| Research | Method | Multiplex Ligation-Dependent Probe Amplification |
| Turnaround | 25 days | |
| Specimen type | genomic DNA |